Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tandon

Showing results (171-180 of 7,825) with videos related to

Pageof 783
Sort By:
The American Journal of Psychiatry|September 1, 2025
Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia?Rajiv Tandon
Indian Pediatrics|September 1, 1982
Systemic hypertension and preventive pediatricsR Tandon
The National Medical Journal of India|June 29, 2005
Reducing vascular disease risk: the undesirable and desirable guidelinesR Tandon
Pest Management Science|December 17, 2013
Degradation kinetics of anilofos in soil and residues in rice crop at harvestShishir Tandon
Methods in Molecular Medicine|March 8, 2011
Receptor-mediated release of inositolphosphates in brain slicesP Tandon
Translational Andrology and Urology|October 31, 2017
Sperm DNA fragmentation testing: where we stand in 2017Salil Tandon
Asian Journal of Psychiatry|January 29, 2021
COVID-19 and the Asian Journal of Psychiatry: Keeping 2020 in the rear-view mirrorRajiv Tandon
Asian Journal of Psychiatry|November 22, 2024
Finally, a non-dopaminergic antipsychotic (xanomeline-trospium) for treatment of schizophrenia: Significance and learningsRajiv Tandon
Asian Journal of Psychiatry|August 29, 2023
Application of computational methods to the study of schizophrenia an exciting but treacherous frontierRajiv Tandon
The Psychiatric Clinics of North America|August 30, 2012
The nosology of schizophrenia: toward DSM-5 and ICD-11Rajiv Tandon
Pageof 783

Showing results (171-180 of 7,825) with videos related to

Sort By:
Pageof 783
The American Journal of Psychiatry|September 1, 2025
Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia?Rajiv Tandon
Indian Pediatrics|September 1, 1982
Systemic hypertension and preventive pediatricsR Tandon
The National Medical Journal of India|June 29, 2005
Reducing vascular disease risk: the undesirable and desirable guidelinesR Tandon
Pest Management Science|December 17, 2013
Degradation kinetics of anilofos in soil and residues in rice crop at harvestShishir Tandon
Methods in Molecular Medicine|March 8, 2011
Receptor-mediated release of inositolphosphates in brain slicesP Tandon
Translational Andrology and Urology|October 31, 2017
Sperm DNA fragmentation testing: where we stand in 2017Salil Tandon
Asian Journal of Psychiatry|January 29, 2021
COVID-19 and the Asian Journal of Psychiatry: Keeping 2020 in the rear-view mirrorRajiv Tandon
Asian Journal of Psychiatry|November 22, 2024
Finally, a non-dopaminergic antipsychotic (xanomeline-trospium) for treatment of schizophrenia: Significance and learningsRajiv Tandon
Asian Journal of Psychiatry|August 29, 2023
Application of computational methods to the study of schizophrenia an exciting but treacherous frontierRajiv Tandon
The Psychiatric Clinics of North America|August 30, 2012
The nosology of schizophrenia: toward DSM-5 and ICD-11Rajiv Tandon
Pageof 783